A期和B期心力衰竭中interstitial fibrosis、左心室重构和功能的影像学评估
本文综述了心肌间质纤维化在A期和B期心力衰竭中的病理机制、CMR T1 mapping技术评估间质纤维化的原理及其与左心室重构和功能的关联。文章总结了临床前和临床观察性研究结果,表明T1 mapping评估的间质纤维化及不良左心室重构是心力衰竭的决定因素,并讨论了技术注意事项和CMR在早期心力衰竭评估中的价值。
要点
- CMR T1 mapping可无创评估心肌间质纤维化,与胶原含量及淀粉样物质浸润相关。
- 间质纤维化和左心室重构可在心力衰竭早期阶段(A期和B期)被检出。
- T1 mapping技术的准确性和可重复性近十年显著提高,但日常应用需扎实的CMR专业知识。
核心结论
- CMR T1 mapping评估的间质纤维化及不良左心室重构是A期和B期心力衰竭的决定因素。
研究设计与样本
- 本文为综述,纳入临床前和临床观察性研究,总结T1 mapping评估间质纤维化与左心室重构及功能的证据。
关键影像表现/征象
- 心肌间质纤维化在组织学上见于高血压性心脏病、糖尿病心肌病、严重主动脉瓣狭窄及衰老过程。
- CMR T1 mapping可间接测量间质间隙特征和细胞外容积,与胶原含量及淀粉样物质等间质浸润密切相关。
诊断标准与关键数值
- CMR已成为评估左心室重构及与间质纤维化相关功能特征的金标准。
临床应用与阅片要点
- 正确使用T1 mapping技术需要日常影像实践中有扎实的CMR专业知识。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Myocardial interstitial fibrosis is part of the advanced disease stage of most cardiovascular pathologies. It has been characterized histologically in various disease settings from hypertensive heart disease and diabetic cardiomyopathy to severe aortic stenosis. It is also involved in the process of aging. In cardiovascular medicine, myocardial interstitial fibrosis is associated with several adverse outcomes, especially heart failure (HF) and sudden cardiac death. Until recently, clinical measures of interstitial fibrosis could only be made by invasive myocardial biopsy. The availability of cardiac magnetic resonance (CMR) T1 mapping techniques allows for the indirect measurement of interstitial space characteristics and extracellular volume size, which is closely correlated with collagen content and interstitial infiltration by amyloid and other molecules. There has been significant improvement in the accuracy and reproducibility of T1 acquisition sequences in the last decade; however, the correct use of this technique requires a solid CMR expertise in daily imaging practice. CMR has become the gold standard to assess left ventricular (LV) remodeling and functional features associated with interstitial fibrosis. These features can be detected in the early stages of HF. The main objective of this paper is to review the relevant results of preclinical and clinical observational studies that demonstrate the prognostic impact of interstitial fibrosis assessed by T1 mapping, as well as adverse left ventricular remodeling, as determinants of HF. Therefore, this review focuses on the pathological mechanisms underlying LV remodeling and interstitial fibrosis, in addition to the technical considerations involved in the assessment of interstitial LV fibrosis by CMR. It provides a thorough review of clinical evidence that demonstrates the association of interstitial fibrosis and other-CMR derived LV phenotypes with Stages A and B HF.
引用
- Pezel T, Viallon M, Croisille P, et al. Imaging Interstitial Fibrosis, Left Ventricular Remodeling, and Function in Stage A and B Heart Failure. JACC Cardiovasc Imaging. 2020. PMID: 32828781. doi:10.1016/j.jcmg.2020.05.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。